Mustang Bio, Inc. financial data

Symbol
MBIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
377 Plantation Street, Worcester, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 53.3 % -83.4%
Debt-to-equity -320 % -347%
Return On Equity 430 %
Return On Assets -195 % -67.9%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 106M shares +16.7%
Entity Public Float 38.7M USD -20.7%
Weighted Average Number of Shares Outstanding, Basic 36.8M shares +351%
Weighted Average Number of Shares Outstanding, Diluted 36.8M shares +351%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 6.54M USD -34%
Operating Income (Loss) -24M USD +60%
Nonoperating Income (Expense) 553K USD -81.1%
Net Income (Loss) Attributable to Parent -23.4M USD +62.6%
Earnings Per Share, Basic -1.56 USD/shares +79.9%
Earnings Per Share, Diluted -1.56 USD/shares +79.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.53M USD -63.1%
Assets, Current 6.06M USD -55.4%
Property, Plant and Equipment, Net 421K USD -88%
Operating Lease, Right-of-Use Asset 92K USD -94.4%
Other Assets, Noncurrent 250K USD -76.9%
Assets 7.19M USD -65%
Accounts Payable, Current 8.76M USD +59.3%
Liabilities, Current 15M USD +6.16%
Operating Lease, Liability, Noncurrent 541K USD -74.5%
Liabilities 15.8M USD -4.28%
Retained Earnings (Accumulated Deficit) -396M USD -6.29%
Stockholders' Equity Attributable to Parent -8.66M USD -316%
Liabilities and Equity 7.19M USD -65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.32M USD +70.1%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 7.32M shares -93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.9M USD -62.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 148M USD +15.3%
Deferred Tax Assets, Gross 148M USD +14.8%
Operating Lease, Liability 983K USD -61.8%
Depreciation 893K USD -61.8%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.08M USD -66%
Property, Plant and Equipment, Gross 7.69M USD 0%
Operating Lease, Liability, Current 442K USD -2.43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 439K USD -43.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 516K USD -28.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 99K USD -83.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 269K USD -61.7%
Deferred Tax Assets, Operating Loss Carryforwards 84.7M USD +12.9%
Preferred Stock, Shares Issued 250K shares 0%
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 274K USD +1.86%
Operating Lease, Payments 156K USD +18.2%
Preferred Stock, Shares Outstanding 250K shares 0%
Deferred Tax Assets, Net of Valuation Allowance 582K USD -46.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%